Ovid Therapeutics to Present at Feb. 25, Mar. 4 and Mar. 11 Investor Conferences
Ovid Therapeutics will present at three investor conferences: Oppenheimer Healthcare Life Sciences on Feb. 25 (11:20 am ET), TD Cowen on Mar. 4 (9:50 am ET) and Leerink Partners Global Healthcare on Mar. 11 (3:00 pm ET). Live webcasts will stream on the company site with replays for 30 days.
1. Scheduled Conference Presentations
Ovid Therapeutics management is slated to speak at three investor conferences over the next two weeks: the 36th Annual Oppenheimer Healthcare Life Sciences Conference on Feb. 25 at 11:20 am ET, the 46th Annual TD Cowen Health Care Conference on Mar. 4 at 9:50 am ET, and the Leerink Partners Global Healthcare Conference on Mar. 11 at 3:00 pm ET.
2. Webcast and Replay Details
Each presentation will be webcast live via the Events & Presentations section of the company’s website, with archived replays accessible for 30 days following the live events to allow broader investor access.
3. Company Pipeline Overview
Ovid is advancing a pipeline of small molecule candidates targeting neuronal hyperexcitability, including OV329, a next-generation GABA-aminotransferase inhibitor for treatment-resistant seizures, as well as OV4071 and other compounds designed to activate the KCC2 transporter for multiple CNS disorders.